BI 655066 Versus Placebo & Active Comparator (Ustekinumab) in Patients With Moderate to Severe Chronic Plaque Psoriasis

NCT02684357 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

577

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis

Interventions

DRUG: risankizumab
DRUG: ustekinumab
DRUG: placebo for risankizumab
DRUG: placebo for ustekinumab

Sponsor

AbbVie

Collaborators

[object Object]